Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2027 - Players Include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals and CureVac Among Others
March 08, 2022 07:13 ET
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Worldwide RNA Interference (RNAi) Drug Delivery" report has been added to ResearchAndMarkets.com's offering. The global RNA interference (RNAi) drug...
The Worldwide Pulmonary Drug Delivery Systems Industry is Expected to Reach $91 Billion by 2030
February 14, 2022 05:33 ET
|
Research and Markets
Dublin, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The "Pulmonary Drug Delivery Systems Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030"...
The Worldwide Pulmonary Drugs Industry is Expected to Reach $69+ Billion by 2027
February 02, 2022 05:18 ET
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Drugs Market (2021-2027) by Drug Class, Indication, Distribution Channel, and Geography, IGR Competitive Analysis, Impact of Covid-19,...
Global Pulmonary Drug Delivery Systems Market Report 2022, Featuring Philips Respironics, GlaxoSmithKline, Boehringer Ingelheim, 3M Healthcare and PARI GmbH
January 17, 2022 04:18 ET
|
Research and Markets
Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- The "Pulmonary Drug Delivery Systems Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering. The pulmonary drug delivery...
$1.6 Billion Worldwide Pharmaceutical Drug Delivery Market Expected to Grow at a CAGR of 5.9% Between 2021 and 2026
December 23, 2021 04:18 ET
|
Research and Markets
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets,...
Pulmonary Drug Delivery Systems Market to Reach $91.12 Billion by 2030, Says Allied Market Research
December 21, 2021 16:00 ET
|
Allied Market Research
Portland, OR, Dec. 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global pulmonary drug delivery systems market generated $49.78 billion in 2020, and...
Global RNA Interference Drug Delivery Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
October 28, 2021 05:58 ET
|
Research and Markets
Dublin, Oct. 28, 2021 (GLOBE NEWSWIRE) -- The "RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
$50+ Billion Drug Delivery Devices Global Markets 2021 - Long-term Forecasts to 2025 & 2030
August 06, 2021 07:53 ET
|
Research and Markets
Dublin, Aug. 06, 2021 (GLOBE NEWSWIRE) -- The "Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....
Global Pulmonary Drugs Market (2021 to 2026) - by Drug Class, Indication, Distribution Channel and Geography
July 07, 2021 04:28 ET
|
Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Drugs Market (2021-2026) by Drug Class, Indication, Distribution Channel, Geography, Competitive Analysis and the Impact of COVID-19...
Global Pulmonary Drugs Market (2020 to 2025) - by Drug Class, Indication, Distribution Channel and Geography
January 20, 2021 06:23 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Drugs Market (2020-2025) by Drug Class, Indication, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19...